Wei Pan, MD
See Publications

Education

  • Medical School:

    Shanghai Medical University

  • Residency:

    University of Chicago (Anesthesiology)

Academic & Clinical Affiliations

Certifications

  • American Board of Anesthesiology

Honors, Awards and Memberships

Publications

4862227 WI5Z8WFT 1 alternatives-to-animal-experimentation 10 date desc Pan 53913 https://www.texasheart.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22T6BHDQPE%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Morkos%20et%20al.%22%2C%22parsedDate%22%3A%222023-03%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMorkos%2C%20M.%2C%20DeLeon%2C%20A.%2C%20Koeckert%2C%20M.%20et%20al.%20%282023%29.%20The%20use%20of%20unilateral%20erector%20spinae%20plane%20block%20in%20minimally%20invasive%20cardiac%20surgery.%20%26lt%3Bi%26gt%3BJ%20Cardiothorac%20Vasc%20Anesth%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B37%26lt%3B%5C%2Fi%26gt%3B%2C%20432%26%23x2013%3B436.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1053%5C%2Fj.jvca.2022.11.039%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1053%5C%2Fj.jvca.2022.11.039%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20use%20of%20unilateral%20erector%20spinae%20plane%20block%20in%20minimally%20invasive%20cardiac%20surgery%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Morkos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aidan%22%2C%22lastName%22%3A%22DeLeon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Koeckert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zachary%22%2C%22lastName%22%3A%22Gray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kenneth%22%2C%22lastName%22%3A%22Liao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wei%22%2C%22lastName%22%3A%22Pan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20A.%22%2C%22lastName%22%3A%22Tolpin%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVES%3A%20To%20examine%20the%20efficacy%20of%20continuous%20unilateral%20erector%20spinae%20plane%20%28ESP%29%20blocks%20in%20minimally%20invasive%20cardiac%20surgery%20patients.%5CnDESIGN%3A%20A%20retrospective%20nonrandomized%20study.%5CnSETTING%3A%20At%20a%20single-center%2C%20tertiary%20academic%20institution.%5CnPARTICIPANTS%3A%20The%20study%20comprised%20129%20adult%20patients%20undergoing%20minimally%20invasive%20cardiac%20surgery%20with%20cardiopulmonary%20bypass%20or%20extracorporeal%20membrane%20oxygenation.%5CnINTERVENTIONS%3A%20Patient%20data%20were%20retrospectively%20collected%20and%20compared.%20Group%201%20patients%20received%20ultrasound-guided%20ESP%20blocks%2C%20and%20group%202%20patients%20underwent%20conventional%20intraoperative%20management%20without%20ESP%20blocks.%20After%20intubation%20in%20the%20group%201%20cohort%2C%2020-to-%2025%20mL%20of%200.25%25%20ropivacaine%20were%20deposited%20beneath%20the%20erector%20spinae%20plane%2C%20along%20with%20catheter%20placement%20for%20continuous%20postoperative%20infusion.%5CnMEASUREMENTS%20AND%20MAIN%20RESULTS%3A%20Patient%20characteristics%20%28ie%2C%20age%2C%20sex%2C%20and%20comorbidities%29%20were%20well-matched%20between%20both%20cohorts.%20The%20total%2048-hour%20opioid%20consumption%2C%20as%20measured%20in%20morphine%20equivalents%20%28mg%29%2C%20was%20significantly%20decreased%20in%20patients%20receiving%20erector%20spinae%20plane%20blocks%20compared%20to%20patients%20receiving%20conventional%20therapy%20%2830.24%20mg%20%5Cu00b1%2023.8%20v%2047.82%20mg%20%5Cu00b1%2053.6%2C%20p%5Cu00a0%3D%5Cu00a00.04%29.%20The%20length%20of%20stay%20in%20the%20intensive%20care%20unit%20%28ICU%29%20also%20was%20reduced%20in%20the%20treatment%20group%20in%20comparison%20to%20the%20control%20group%20%281.99%20days%20%5Cu00b1%201.7%20v%202.65%20days%20%5Cu00b1%202.4%2C%20p%5Cu00a0%3D%5Cu00a00.03%29.%20Lastly%2C%20patients%20receiving%20the%20blocks%20benefitted%20from%20a%20decrease%20in%20overall%20hospital%20length%20of%20stay%20when%20compared%20to%20the%20control%20group%20%285.93%20days%20%5Cu00b1%202.4%20v%207.35%20days%20%5Cu00b1%205.8%2C%20p%5Cu00a0%3D%5Cu00a00.04%29.%5CnCONCLUSION%3A%20Erector%20spinae%20plane%20catheter%20use%20may%20safely%20improve%20postoperative%20measures%2C%20including%20decreased%20opioid%20consumption%20and%20improved%20pain%20relief%2C%20as%20well%20as%20reductions%20in%20ICU%20and%20hospital%20lengths%20of%20stay%20in%20patients%20undergoing%20minimally%20invasive%20cardiac%20surgery.%22%2C%22date%22%3A%22Mar%202023%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1053%5C%2Fj.jvca.2022.11.039%22%2C%22ISSN%22%3A%221532-8422%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22WI5Z8WFT%22%2C%22C8D9UJBP%22%2C%22C2VFJYPK%22%2C%22FA6KSIY7%22%5D%2C%22dateModified%22%3A%222023-02-14T20%3A17%3A42Z%22%7D%7D%2C%7B%22key%22%3A%22QKZ9YEDB%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Shi%20et%20al.%22%2C%22parsedDate%22%3A%222022-07-26%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BShi%2C%20J.%2C%20Zhou%2C%20C.%2C%20%26lt%3Bstrong%26gt%3BPan%26lt%3B%5C%2Fstrong%26gt%3B%2C%20W.%20et%20al.%20%282022%29.%20Effect%20of%20high-%20vs%20low-dose%20tranexamic%20acid%20infusion%20on%20need%20for%20red%20blood%20cell%20transfusion%20and%20adverse%20events%20in%20patients%20undergoing%20cardiac%20surgery%3A%20The%20OPTIMAL%20randomized%20clinical%20trial.%20%26lt%3Bi%26gt%3BJAMA%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B328%26lt%3B%5C%2Fi%26gt%3B%2C%20336%26%23x2013%3B347.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1001%5C%2Fjama.2022.10725%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1001%5C%2Fjama.2022.10725%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Effect%20of%20high-%20vs%20low-dose%20tranexamic%20acid%20infusion%20on%20need%20for%20red%20blood%20cell%20transfusion%20and%20adverse%20events%20in%20patients%20undergoing%20cardiac%20surgery%3A%20The%20OPTIMAL%20randomized%20clinical%20trial%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia%22%2C%22lastName%22%3A%22Shi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chenghui%22%2C%22lastName%22%3A%22Zhou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wei%22%2C%22lastName%22%3A%22Pan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hansong%22%2C%22lastName%22%3A%22Sun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sheng%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wei%22%2C%22lastName%22%3A%22Feng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Weijian%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhaoyun%22%2C%22lastName%22%3A%22Cheng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yang%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhe%22%2C%22lastName%22%3A%22Zheng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22OPTIMAL%20Study%20Group%22%7D%5D%2C%22abstractNote%22%3A%22Importance%3A%20Tranexamic%20acid%20is%20recommended%20for%20reducing%20blood%20loss%20and%20transfusion%20in%20cardiac%20surgery.%20However%2C%20it%20remains%20unknown%20whether%20a%20high%20dose%20of%20tranexamic%20acid%20provides%20better%20blood-sparing%20effect%20than%20a%20low%20dose%20without%20increasing%20the%20risk%20of%20thrombotic%20complications%20or%20seizures%20in%20cardiac%20surgery.%5CnObjective%3A%20To%20compare%20the%20efficacy%20and%20adverse%20events%20of%20high-dose%20vs%20low-dose%20tranexamic%20acid%20in%20patients%20undergoing%20cardiac%20surgery%20with%20cardiopulmonary%20bypass.%5CnDesign%2C%20Setting%2C%20and%20Participants%3A%20Multicenter%2C%20double-blind%2C%20randomized%20clinical%20trial%20among%20adult%20patients%20undergoing%20cardiac%20surgery%20with%20cardiopulmonary%20bypass.%20The%20study%20enrolled%203079%20patients%20at%204%20hospitals%20in%20China%20from%20December%2026%2C%202018%2C%20to%20April%2021%2C%202021%3B%20final%20follow-up%20was%20on%20May%2021%2C%202021.%5CnInterventions%3A%20Participants%20received%20either%20a%20high-dose%20tranexamic%20acid%20regimen%20comprising%20a%2030-mg%5C%2Fkg%20bolus%2C%20a%2016-mg%5C%2Fkg%5C%2Fh%20maintenance%20dose%2C%20and%20a%202-mg%5C%2Fkg%20prime%20%28n%5Cu2009%3D%5Cu20091525%29%20or%20a%20low-dose%20regimen%20comprising%20a%2010-mg%5C%2Fkg%20bolus%2C%20a%202-mg%5C%2Fkg%5C%2Fh%20maintenance%20dose%2C%20and%20a%201-mg%5C%2Fkg%20prime%20%28n%5Cu2009%3D%5Cu20091506%29.%5CnMain%20Outcomes%20and%20Measures%3A%20The%20primary%20efficacy%20end%20point%20was%20the%20rate%20of%20allogeneic%20red%20blood%20cell%20transfusion%20after%20start%20of%20operation%20%28superiority%20hypothesis%29%2C%20and%20the%20primary%20safety%20end%20point%20was%20a%20composite%20of%20the%2030-day%20postoperative%20rate%20of%20mortality%2C%20seizure%2C%20kidney%20dysfunction%20%28stage%202%20or%203%20Kidney%20Disease%3A%20Improving%20Global%20Outcomes%20%5BKDIGO%5D%20criteria%29%2C%20and%20thrombotic%20events%20%28myocardial%20infarction%2C%20ischemic%20stroke%2C%20deep%20vein%20thrombosis%2C%20and%20pulmonary%20embolism%29%20%28noninferiority%20hypothesis%20with%20a%20margin%20of%205%25%29.%20There%20were%2015%20secondary%20end%20points%2C%20including%20the%20individual%20components%20of%20the%20primary%20safety%20end%20point.%5CnResults%3A%20Among%203079%20patients%20who%20were%20randomized%20to%20treatment%20groups%20%28mean%20age%2C%2052.8%20years%3B%2038.1%25%20women%29%2C%203031%20%2898.4%25%29%20completed%20the%20trial.%20Allogeneic%20red%20blood%20cell%20transfusion%20occurred%20in%20333%20of%201525%20patients%20%2821.8%25%29%20in%20the%20high-dose%20group%20and%20391%20of%201506%20patients%20%2826.0%25%29%20in%20the%20low-dose%20group%20%28risk%20difference%20%5BRD%5D%2C%20-4.1%25%20%5B1-sided%2097.55%25%20CI%2C%20-%5Cu221e%20to%20-1.1%25%5D%3B%20relative%20risk%2C%200.84%20%5B1-sided%2097.55%25%20CI%2C%20-%5Cu221e%20to%200.96%3B%20P%5Cu2009%3D%5Cu2009.004%5D%29.%20The%20composite%20of%20postoperative%20seizure%2C%20thrombotic%20events%2C%20kidney%20dysfunction%2C%20and%20death%20occurred%20in%20265%20patients%20in%20the%20high-dose%20group%20%2817.6%25%29%20and%20249%20patients%20in%20the%20low-dose%20group%20%2816.8%25%29%20%28RD%2C%200.8%25%3B%201-sided%2097.55%25%20CI%2C%20-%5Cu221e%20to%203.9%25%3B%20P%5Cu2009%3D%5Cu2009.003%20for%20noninferiority%29.%20Fourteen%20of%20the%2015%20prespecified%20secondary%20end%20points%20were%20not%20significantly%20different%20between%20groups%2C%20including%20seizure%2C%20which%20occurred%20in%2015%20patients%20%281.0%25%29%20in%20the%20high-dose%20group%20and%206%20patients%20%280.4%25%29%20in%20the%20low-dose%20group%20%28RD%2C%200.6%25%3B%2095%25%20CI%2C%20-0.0%25%20to%201.2%25%3B%20P%5Cu2009%3D%5Cu2009.05%29.%5CnConclusions%20and%20Relevance%3A%20Among%20patients%20who%20underwent%20cardiac%20surgery%20with%20cardiopulmonary%20bypass%2C%20high-dose%20compared%20with%20low-dose%20tranexamic%20acid%20infusion%20resulted%20in%20a%20modest%20statistically%20significant%20reduction%20in%20the%20proportion%20of%20patients%20who%20received%20allogeneic%20red%20blood%20cell%20transfusion%20and%20met%20criteria%20for%20noninferiority%20with%20respect%20to%20a%20composite%20primary%20safety%20end%20point%20consisting%20of%2030-day%20mortality%2C%20seizure%2C%20kidney%20dysfunction%2C%20and%20thrombotic%20events.%5CnTrial%20Registration%3A%20ClinicalTrials.gov%20Identifier%3A%20NCT03782350.%22%2C%22date%22%3A%22July%2026%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1001%5C%2Fjama.2022.10725%22%2C%22ISSN%22%3A%221538-3598%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22WI5Z8WFT%22%2C%22VTWWYEIB%22%5D%2C%22dateModified%22%3A%222022-09-02T20%3A12%3A14Z%22%7D%7D%2C%7B%22key%22%3A%22XHNVKF8H%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Qiu%20et%20al.%22%2C%22parsedDate%22%3A%222021%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BQiu%2C%20J.%2C%20Luo%2C%20X.%2C%20Wu%2C%20J.%20et%20al.%20%282021%29.%20A%20new%20aortic%20arch%20dissection%20classification%3A%20the%20Fuwai%20classification.%20%26lt%3Bi%26gt%3BFront%20Cardiovasc%20Med%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B8%26lt%3B%5C%2Fi%26gt%3B%2C%20710281.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffcvm.2021.710281%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffcvm.2021.710281%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20new%20aortic%20arch%20dissection%20classification%3A%20the%20Fuwai%20classification%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juntao%22%2C%22lastName%22%3A%22Qiu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xinjin%22%2C%22lastName%22%3A%22Luo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jinlin%22%2C%22lastName%22%3A%22Wu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wei%22%2C%22lastName%22%3A%22Pan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qian%22%2C%22lastName%22%3A%22Chang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiangyang%22%2C%22lastName%22%3A%22Qian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiaogang%22%2C%22lastName%22%3A%22Sun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bo%22%2C%22lastName%22%3A%22Wei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liang%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shen%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wenxiang%22%2C%22lastName%22%3A%22Jiang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cuntao%22%2C%22lastName%22%3A%22Yu%22%7D%5D%2C%22abstractNote%22%3A%22Aims%3A%20We%20describe%20a%20new%20aortic%20arch%20dissection%20%28AcD%29%20classification%2C%20which%20we%20have%20called%20the%20Fuwai%20classification.%20We%20then%20compare%20the%20clinical%20characteristics%20and%20long-term%20prognoses%20of%20different%20classifications.%20Methods%3A%20All%20AcD%20patients%20who%20underwent%20surgical%20procedures%20at%20Fuwai%20Hospital%20from%202010%20to%202015%20were%20included%20in%20the%20study.%20AcD%20procedures%20are%20divided%20into%20three%20types%3A%20Fuwai%20type%20Cp%2C%20Ct%2C%20and%20Cd.%20Type%20Cp%20is%20defined%20as%20the%20innominate%20artery%20or%20combined%20with%20the%20left%20carotid%20artery%20involved.%20Type%20Cd%20is%20defined%20as%20the%20left%20subclavian%20artery%20or%20combined%20with%20the%20left%20carotid%20artery%20involved.%20All%20other%20AcD%20surgeries%20are%20defined%20as%20type%20Ct.%20The%20Chi-square%20test%20was%20adopted%20for%20the%20pairwise%20comparison%20among%20the%20three%20types.%20Kaplan-Meier%20was%20used%20for%20the%20analysis%20of%20long-term%20survival%20and%20survival%20free%20of%20reoperation.%20Results%3A%20In%20total%2C%201%2C063%20AcD%20patients%20were%20enrolled%20from%202010%20to%202015%3A%2054%20patients%20were%20type%20Cp%2C%20832%20were%20type%20Ct%2C%20and%20177%20were%20type%20Cd.%20The%20highest%20operation%20proportion%20of%20Cp%2C%20Ct%20and%20Cd%20were%20partial%20arch%20replacement%2C%20total%20arch%20replacement%2C%20and%20TEVAR.%20The%20surgical%20mortality%20in%20type%20Ct%20was%20higher%20compared%20to%20type%20Cd%20%28Ct%20vs.%20Cd%20%3D%209.38%20vs.%201.69%25%2C%20p%20%26lt%3B%200.01%29%20and%20type%20Cp%20%28Ct%20vs.%20Cp%20%3D%209.38%20vs.%201.85%25%2C%20p%20%3D%200.06%29.%20There%20was%20no%20difference%20in%20surgical%20mortality%20of%20type%20Cp%20and%20Cd%20%28p%20%3D%200.93%29.%20There%20were%20no%20significant%20differences%20in%20the%20long-term%20survival%20rates%20%28p%20%3D%200.38%29%20and%20free%20of%20aorta-related%20re-operations%20%28p%20%3D%200.19%29.%20Conclusion%3A%20The%20Fuwai%20classification%20is%20used%20to%20distinguish%20different%20AcDs.%20Different%20AcDs%20have%20different%20surgical%20mortality%20and%20use%20different%20operation%20methods%2C%20but%20they%20have%20similar%20long-term%20results.%22%2C%22date%22%3A%222021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3389%5C%2Ffcvm.2021.710281%22%2C%22ISSN%22%3A%222297-055X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22WI5Z8WFT%22%5D%2C%22dateModified%22%3A%222021-10-29T19%3A16%3A13Z%22%7D%7D%2C%7B%22key%22%3A%22IUSTAEU4%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Schutz%20et%20al.%22%2C%22parsedDate%22%3A%222020-05-01%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BSchutz%2C%20A.%2C%20Zhang%2C%20Q.%2C%20Bertapelle%2C%20K.%20et%20al.%20%282020%29.%20Del%20Nido%20cardioplegia%20in%20coronary%20surgery%3A%20a%20propensity-matched%20analysis.%20%26lt%3Bi%26gt%3BInteract%20Cardiovasc%20Thorac%20Surg%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B30%26lt%3B%5C%2Fi%26gt%3B%2C%20699%26%23x2013%3B705.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Ficvts%5C%2Fivaa010%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Ficvts%5C%2Fivaa010%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Del%20Nido%20cardioplegia%20in%20coronary%20surgery%3A%20a%20propensity-matched%20analysis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%22%2C%22lastName%22%3A%22Schutz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qianzi%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kimberly%22%2C%22lastName%22%3A%22Bertapelle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicholas%22%2C%22lastName%22%3A%22Beecher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%22%2C%22lastName%22%3A%22Long%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vei-Vei%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wei%22%2C%22lastName%22%3A%22Pan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Arcaro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ravi%22%2C%22lastName%22%3A%22Ghanta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ernesto%22%2C%22lastName%22%3A%22Jimenez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20A.%22%2C%22lastName%22%3A%22Ott%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriel%22%2C%22lastName%22%3A%22Loor%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVES%3A%20Del%20Nido%20cardioplegia%20%28DNC%29%20has%20been%20shown%20to%20be%20safe%20in%20adults%20with%20normal%20coronary%20arteries%20who%20are%20undergoing%20valve%20surgery.%20This%20study%20compared%20the%20effects%20of%20DNC%20versus%20traditional%20blood-based%20cardioplegia%20on%20postoperative%20complications%20in%20patients%20who%20underwent%20coronary%20artery%20bypass%20grafting%20%28CABG%29.%5CnMETHODS%3A%20A%20retrospective%20analysis%20was%20performed%20on%20863%20patients%20who%20underwent%20CABG%20with%20DNC%20%28n%5Cu2009%3D%5Cu2009420%29%20or%20control%20cardioplegia%20%28CC%29%20%28n%5Cu2009%3D%5Cu2009443%29%20between%202014%20and%202017.%20The%20full%20cohort%20of%20DNC%20and%20CC%20recipients%2C%20as%20well%20as%20propensity%20score-matched%20pairs%2C%20was%20compared%20regarding%20preoperative%20risk%20variables%20and%20outcomes.%5CnRESULTS%3A%20The%20DNC%20and%20CC%20groups%20showed%20no%20significant%20differences%20in%20mean%20cardiopulmonary%20bypass%20time%20%2853.09%20vs%2052.10%5Cu2009min%2C%20P%5Cu2009%3D%5Cu20090.206%29%20or%20aortic%20cross-clamp%20time%20%2832.82%20vs%2033.28%5Cu2009min%2C%20P%5Cu2009%3D%5Cu20090.967%29.%20The%20groups%20also%20showed%20no%20difference%20in%20operative%20mortality%20%282.1%25%20vs%202.5%25%2C%20P%5Cu2009%3D%5Cu20090.734%29%3B%20however%2C%20DNC%20use%20resulted%20in%20lower%20rates%20of%20overall%20infections%20%281.7%25%20vs%204.3%25%2C%20P%5Cu2009%3D%5Cu20090.024%29%2C%20total%20sternal%20infections%20%280.9%25%20vs%203.2%25%2C%20P%5Cu2009%3D%5Cu20090.023%29%2C%20postoperative%20atrial%20fibrillation%20%2823.8%25%20vs%2030.7%25%2C%20P%5Cu2009%3D%5Cu20090.023%29%20and%20postoperative%20ventricular%20tachycardia%20%280.5%25%20vs%203.4%25%2C%20P%5Cu2009%3D%5Cu20090.002%29.%20A%20propensity-matching%20analysis%20%28n%5Cu2009%3D%5Cu2009335%20pairs%29%20showed%20similar%20statistically%20significant%20decreases%20with%20DNC.%5CnCONCLUSIONS%3A%20In%20this%20large%20cohort%20of%20CABG%20patients%2C%20DNC%20was%20shown%20as%20a%20safe%20alternative%20to%20CC%20and%20was%20associated%20with%20lower%20postoperative%20dysrhythmia%20and%20infection%20rates.%20These%20findings%20show%20that%20DNC%20is%20safe%20and%20effective%20in%20patients%20whose%20operative%20interventions%20may%20require%20only%20single-dosing%20cardioplegia%3B%20its%20use%20in%20longer%20cases%20should%20be%20further%20explored%20given%20its%20low%20complication%20rate.%22%2C%22date%22%3A%22May%2001%2C%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Ficvts%5C%2Fivaa010%22%2C%22ISSN%22%3A%221569-9285%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GNSKWJNU%22%2C%22XQD53WZF%22%2C%22WI5Z8WFT%22%2C%22WJ4DNEJG%22%2C%22AFDZBLNB%22%5D%2C%22dateModified%22%3A%222022-02-04T15%3A51%3A51Z%22%7D%7D%2C%7B%22key%22%3A%22APVZQAB7%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Shi%20et%20al.%22%2C%22parsedDate%22%3A%222020-04%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BShi%2C%20J.%2C%20Zhou%2C%20C.%2C%20Liu%2C%20S.%20et%20al.%20%282020%29.%20Outcome%20impact%20of%20different%20tranexamic%20acid%20regimens%20in%20cardiac%20surgery%20with%20cardiopulmonary%20bypass%20%28OPTIMAL%29%3A%20Rationale%2C%20design%2C%20and%20study%20protocol%20of%20a%20multicenter%20randomized%20controlled%20trial.%20%26lt%3Bi%26gt%3BAm%20Heart%20J%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B222%26lt%3B%5C%2Fi%26gt%3B%2C%20147%26%23x2013%3B156.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ahj.2019.09.010%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ahj.2019.09.010%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Outcome%20impact%20of%20different%20tranexamic%20acid%20regimens%20in%20cardiac%20surgery%20with%20cardiopulmonary%20bypass%20%28OPTIMAL%29%3A%20Rationale%2C%20design%2C%20and%20study%20protocol%20of%20a%20multicenter%20randomized%20controlled%20trial%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia%22%2C%22lastName%22%3A%22Shi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chenghui%22%2C%22lastName%22%3A%22Zhou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sheng%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hansong%22%2C%22lastName%22%3A%22Sun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yang%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fuxia%22%2C%22lastName%22%3A%22Yan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wei%22%2C%22lastName%22%3A%22Pan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhe%22%2C%22lastName%22%3A%22Zheng%22%7D%5D%2C%22abstractNote%22%3A%22Tranexamic%20acid%20%28TxA%29%20reduces%20perioperative%20blood%20transfusion%20in%20cardiac%20surgery%3B%20however%2C%20the%20optimal%20dose%20of%20TxA%20remains%20unknown.%20METHODS%20AND%20RESULTS%3A%20This%20large-scale%2C%20double-blind%2C%20randomized%20controlled%20trial%20with%20a%201-year%20follow-up%20enrolls%20patients%20undergoing%20elective%20cardiac%20surgery%20with%20cardiopulmonary%20bypass.%20Patients%20are%20randomly%20assigned%201%3A1%20into%20either%20the%20high-dose%20TxA%20group%20%28intravenous%20bolus%20%5B30%20mg%5C%2Fkg%5D%20after%20anesthesia%20followed%20by%20intravenous%20maintenance%20%5B16%20mg%5C%2Fkg%5C%2Fh%5D%20throughout%20the%20operation%2C%20and%20a%20pump%20prime%20dose%20of%202%20mg%5C%2Fkg%29%20or%20the%20low-dose%20TxA%20group%20%28intravenous%20bolus%20and%20maintenance%20are%2010%20mg%5C%2Fkg%20and%202%20mg%5C%2Fkg%5C%2Fh%2C%20respectively%2C%20and%20a%20pump%20prime%20dose%20of%201%20mg%5C%2Fkg%29.%20The%20primary%20efficacy%20end%20point%20is%20the%20rate%20of%20perioperative%20allogeneic%20red%20blood%20cell%20%28RBC%29%20transfusion%20defined%20as%20the%20number%20%28%25%29%20of%20patients%20who%20will%20receive%20at%20least%201%20RBC%20unit%20from%20operation%20day%20to%20discharge.%20The%20primary%20safety%20end%20point%20is%20the%2030-day%20rate%20of%20the%20composite%20of%20perioperative%20seizures%2C%20renal%20dysfunction%2C%20myocardial%20infarction%2C%20ischemic%20stroke%2C%20deep%20vein%20thrombosis%2C%20pulmonary%20embolism%2C%20and%20all-cause%20mortality.%20The%20secondary%20end%20points%20are%20perioperative%20allogeneic%20RBC%20transfusion%20volume%2C%20the%20non-RBC%20blood%20transfusion%20rate%2C%20postoperative%20bleeding%2C%20reoperation%20rate%2C%20mechanical%20ventilation%20duration%2C%20intensive%20care%20unit%20stay%2C%20hospital%20length%20of%20stay%2C%20total%20hospitalization%20cost%2C%20each%20component%20of%20composite%20primary%20safety%20end%20point%2C%20and%20the%206-month%5C%2F1-year%20follow-up%20mortality%20and%20morbidity.%20We%20estimated%20a%20sample%20size%20of%203%2C008%20participants.%20CONCLUSIONS%3A%20The%20study%20is%20designed%20to%20identify%20a%20TxA%20dose%20with%20maximal%20efficacy%20and%20minimal%20complications.%20We%20hypothesize%20that%20the%20high%20dose%20has%20superior%20efficacy%20and%20noninferior%20safety%20to%20the%20low%20dose.%22%2C%22date%22%3A%22Apr%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ahj.2019.09.010%22%2C%22ISSN%22%3A%221097-6744%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22WI5Z8WFT%22%5D%2C%22dateModified%22%3A%222022-04-26T13%3A37%3A30Z%22%7D%7D%2C%7B%22key%22%3A%2276A747W6%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Curtis%20et%20al.%22%2C%22parsedDate%22%3A%222017-09%22%2C%22numChildren%22%3A5%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BCurtis%2C%20M.%2C%20Deng%2C%20Y.%2C%20Lee%2C%20V.-V.%20et%20al.%20%282017%29.%20Effect%20of%20dose%20and%20timing%20of%20preoperative%20statins%20on%20mortality%20after%20coronary%20artery%20bypass%20surgery.%20%26lt%3Bi%26gt%3BAnn%20Thorac%20Surg%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B104%26lt%3B%5C%2Fi%26gt%3B%2C%20782%26%23x2013%3B789.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.athoracsur.2016.12.043%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.athoracsur.2016.12.043%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Effect%20of%20dose%20and%20timing%20of%20preoperative%20statins%20on%20mortality%20after%20coronary%20artery%20bypass%20surgery%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Curtis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yi%22%2C%22lastName%22%3A%22Deng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vei-Vei%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22MacArthur%20A.%22%2C%22lastName%22%3A%22Elayda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20S.%22%2C%22lastName%22%3A%22Coselli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20D.%22%2C%22lastName%22%3A%22Collard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wei%22%2C%22lastName%22%3A%22Pan%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Preoperative%20statin%20administration%20is%20associated%20with%20reduced%20mortality%20risk%20after%20a%20coronary%20artery%20bypass%20graft%20operation.%20However%2C%20the%20optimal%20dose%20and%20timing%20are%20unknown.%5CnMETHODS%3A%20We%20retrospectively%20reviewed%20data%20from%203%2C025%20primary%20isolated%20coronary%20artery%20bypass%20graft%20surgery%20patients%20at%20our%20institution.%20Patients%20were%20divided%20into%20three%20groups%2C%20according%20to%20timing%20of%20their%20preoperative%20statin%3A%2024%20hours%20or%20less%20%28n%5Cu00a0%3D%201%2C788%29%2C%2024%20to%2072%20hours%20%28n%5Cu00a0%3D%20452%29%2C%20or%20more%20than%2072%20hours%20before%20operation%20or%20no%20dose%20%28n%5Cu00a0%3D%20781%29.%20We%20then%20grouped%20patients%20by%20preoperative%20dose%3A%20no%20statin%20%28n%5Cu00a0%3D%5Cu00a0739%29%2C%2020%20mg%20or%20less%20%28n%5Cu00a0%3D%20920%29%2C%20or%20more%20than%2020%20mg%20%28n%5Cu00a0%3D%5Cu00a01%2C284%29%20atorvastatin%20or%20equivalent.%20Primary%20outcome%20was%2030-day%20all-cause%20postoperative%20mortality.%5CnRESULTS%3A%20Thirty-day%20all-cause%20mortality%20was%20significantly%20lower%20for%20patients%20taking%20a%20statin%2024%20hours%20or%20less%20preoperatively%20%281.7%25%29%20compared%20with%2024%20to%2072%20hours%20%282.9%25%29%2C%20more%20than%2072%20hours%2C%20or%20no%20dose%20%283.8%25%29.%20Multivariate%20analysis%20of%20a%20propensity-matched%20cohort%20showed%20taking%20statins%2024%20hours%20or%20less%20preoperatively%20was%20associated%20with%20reduced%2030-day%20all-cause%20mortality%20%28odds%20ratio%200.52%2C%2095%25%20confidence%20interval%3A%200.28%20to%200.98%2C%20p%5Cu00a0%3D%200.04%29%20versus%20more%20than%2024%20hours%20or%20no%20dose.%20For%20preoperative%20statin%20dose%2C%2030-day%20all-cause%20mortality%20was%20significantly%20lower%20when%20taking%2020%20mg%20or%20less%281.8%25%29%20or%20more%20than%2020%20mg%20atorvastatin%20or%20equivalent%20%282.1%25%29%20than%20when%20taking%20none%20%283.8%25%29.%20In%20multivariate%20analysis%20of%20the%20propensity-matched%20cohort%2C%20more%20than%2020%20mg%20preoperative%20dose%20was%20associated%20with%20a%2068%25%20reduction%20of%2030-day%20all-cause%20mortality%20%28odds%20ratio%200.32%2C%2095%25%20confidence%20interval%3A%200.13%20to%200.82%2C%20p%5Cu00a0%3D%200.02%29%20compared%20with%20no%20preoperative%20statin.%20However%2C%20a%2020%20mg%20or%20less%20preoperative%20dose%20showed%20no%20mortality%20reduction.%5CnCONCLUSIONS%3A%20Both%20statin%20use%2024%20hours%20or%20less%20preoperatively%20and%20preoperative%20statin%20dose%20of%20more%20than%2020%20mg%20were%20independently%20associated%20with%20decreased%2030-day%20all-cause%20mortality%20after%20coronary%20artery%20bypass%20graft%20surgery.%22%2C%22date%22%3A%22Sep%202017%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.athoracsur.2016.12.043%22%2C%22ISSN%22%3A%221552-6259%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22BJSZ96GT%22%2C%22394YLKLW%22%2C%22WI5Z8WFT%22%5D%2C%22dateModified%22%3A%222022-01-24T21%3A56%3A09Z%22%7D%7D%2C%7B%22key%22%3A%22XK67GENH%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Wei%20et%20al.%22%2C%22parsedDate%22%3A%222016-12-07%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BWei%2C%20P.%2C%20Cao%2C%20Y.%2C%20Zhang%2C%20Y.%20et%20al.%20%282016%29.%20On%20robust%20association%20testing%20for%20quantitative%20traits%20and%20rare%20variants.%20%26lt%3Bi%26gt%3BG3%20%28Bethesda%29%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B6%26lt%3B%5C%2Fi%26gt%3B%2C%203941%26%23x2013%3B3950.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1534%5C%2Fg3.116.035485%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1534%5C%2Fg3.116.035485%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22On%20robust%20association%20testing%20for%20quantitative%20traits%20and%20rare%20variants%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peng%22%2C%22lastName%22%3A%22Wei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ying%22%2C%22lastName%22%3A%22Cao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yiwei%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhiyuan%22%2C%22lastName%22%3A%22Xu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Il-Youp%22%2C%22lastName%22%3A%22Kwak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%22%2C%22lastName%22%3A%22Boerwinkle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wei%22%2C%22lastName%22%3A%22Pan%22%7D%5D%2C%22abstractNote%22%3A%22With%20the%20advance%20of%20sequencing%20technologies%2C%20it%20has%20become%20a%20routine%20practice%20to%20test%20for%20association%20between%20a%20quantitative%20trait%20and%20a%20set%20of%20rare%20variants%20%28RVs%29.%20While%20a%20number%20of%20RV%20association%20tests%20have%20been%20proposed%2C%20there%20is%20a%20dearth%20of%20studies%20on%20the%20robustness%20of%20RV%20association%20testing%20for%20nonnormal%20distributed%20traits%2C%20e.g.%2C%20due%20to%20skewness%2C%20which%20is%20ubiquitous%20in%20cohort%20studies.%20By%20extensive%20simulations%2C%20we%20demonstrate%20that%20commonly%20used%20RV%20tests%2C%20including%20sequence%20kernel%20association%20test%20%28SKAT%29%20and%20optimal%20unified%20SKAT%20%28SKAT-O%29%2C%20are%20not%20robust%20to%20heavy-tailed%20or%20right-skewed%20trait%20distributions%20with%20inflated%20type%20I%20error%20rates%3B%20in%20contrast%2C%20the%20adaptive%20sum%20of%20powered%20score%20%28aSPU%29%20test%20is%20much%20more%20robust.%20Here%20we%20further%20propose%20a%20robust%20version%20of%20the%20aSPU%20test%2C%20called%20aSPUr.%20We%20conduct%20extensive%20simulations%20to%20evaluate%20the%20power%20of%20the%20tests%2C%20finding%20that%20for%20a%20larger%20number%20of%20RVs%2C%20aSPU%20is%20often%20more%20powerful%20than%20SKAT%20and%20SKAT-O%2C%20owing%20to%20its%20high%20data-adaptivity.%20We%20also%20compare%20different%20tests%20by%20conducting%20association%20analysis%20of%20triglyceride%20levels%20using%20the%20NHLBI%20ESP%20whole-exome%20sequencing%20data.%20The%20QQ%20plots%20for%20SKAT%20and%20SKAT-O%20were%20severely%20inflated%20%28%5Cu03bb%20%3D%201.89%20and%201.78%2C%20respectively%29%2C%20while%20those%20for%20aSPU%20and%20aSPUr%20behaved%20normally.%20Due%20to%20its%20relatively%20high%20robustness%20to%20outliers%20and%20high%20power%20of%20the%20aSPU%20test%2C%20we%20recommend%20its%20use%20complementary%20to%20SKAT%20and%20SKAT-O.%20If%20there%20is%20evidence%20of%20inflated%20type%20I%20error%20rate%20from%20the%20aSPU%20test%2C%20we%20would%20recommend%20the%20use%20of%20the%20more%20robust%2C%20but%20less%20powerful%2C%20aSPUr%20test.%22%2C%22date%22%3A%22Dec%2007%2C%202016%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1534%5C%2Fg3.116.035485%22%2C%22ISSN%22%3A%222160-1836%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22VYVQ37MR%22%2C%22WI5Z8WFT%22%5D%2C%22dateModified%22%3A%222018-05-14T21%3A51%3A20Z%22%7D%7D%2C%7B%22key%22%3A%22EJ93DZF9%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Deng%20et%20al.%22%2C%22parsedDate%22%3A%222015-12%22%2C%22numChildren%22%3A5%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BDeng%2C%20Y.%2C%20Pisklak%2C%20P.%20V.%2C%20Lee%2C%20V.-V.%20et%20al.%20%282015%29.%20Association%20between%20preoperative%20aspirin-dosing%20strategy%20and%20mortality%20after%20coronary%20artery%20bypass%20graft%20surgery.%20%26lt%3Bi%26gt%3BAnn%20Surg%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B262%26lt%3B%5C%2Fi%26gt%3B%2C%201150%26%23x2013%3B1156.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FSLA.0000000000000951%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FSLA.0000000000000951%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Association%20between%20preoperative%20aspirin-dosing%20strategy%20and%20mortality%20after%20coronary%20artery%20bypass%20graft%20surgery%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yi%22%2C%22lastName%22%3A%22Deng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%20V.%22%2C%22lastName%22%3A%22Pisklak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vei-Vei%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20A.%22%2C%22lastName%22%3A%22Tolpin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20D.%22%2C%22lastName%22%3A%22Collard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22MacArthur%20A.%22%2C%22lastName%22%3A%22Elayda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%22%2C%22lastName%22%3A%22Coselli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wei%22%2C%22lastName%22%3A%22Pan%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVE%3A%20To%20determine%20whether%20preoperative%20aspirin-acetylsalicylic%20acid%20%28ASA%29-timing%20or%20dose%20independently%20affects%2030-day%20all-cause%20mortality.%5CnBACKGROUND%3A%20Preoperative%20ASA%20administration%20is%20associated%20with%20reduced%20morbidity%20and%20mortality%20after%20coronary%20artery%20bypass%20graft%20%28CABG%29.%20However%2C%20data%20are%20lacking%20regarding%20optimal%20timing%20and%20dosing%20of%20ASA.%5CnMETHODS%3A%20We%20retrospectively%20reviewed%20data%20from%203018%20consecutive%20patients%20who%20underwent%20CABG%20surgery%20between%20July%202005%20and%20May%202011.%20Patients%20were%20assigned%20to%203%20groups%20according%20to%20the%20time%20of%20the%20last%20preoperative%20ASA%20dose%3A%20%281%29%2024%5Cu200ahours%20or%20less%20preoperatively%20%28n%5Cu200a%3D%5Cu200a1173%29%2C%20%282%29%20between%2024%20and%2072%5Cu200ahours%20%28n%5Cu200a%3D%5Cu200a876%29%2C%20and%20%283%29%20more%20than%2072%5Cu200ahours%20or%20none%20%28n%5Cu200a%3D%5Cu200a969%29.%20In%20a%20separate%20analysis%2C%20patients%20were%20grouped%20according%20to%20ASA%20dose%3A%2081%5Cu200amg%20%28n%5Cu200a%3D%5Cu200a1285%29%2C%20325%5Cu200amg%20%28n%5Cu200a%3D%5Cu200a1004%29%2C%20and%20none%20%28n%5Cu200a%3D%5Cu200a543%29.%20The%20primary%20outcome%20was%2030-day%20all-cause%20mortality.%5CnRESULTS%3A%20The%2030-day%20mortality%20rate%20was%20significantly%20lower%20in%20patients%20who%20took%20ASA%2024%5Cu200ahours%20or%20less%20preoperatively%20%281.5%25%29%20than%20in%20those%20who%20took%20it%20between%2024%20and%2072%5Cu200ahours%20%283.2%25%29%20or%20more%20than%2072%5Cu200ahours%20or%20none%20%282.9%25%29.%20Multivariate%20analysis%20showed%20that%20ASA%20within%2024%5Cu200ahours%20preoperatively%20was%20associated%20with%20reduced%20mortality%20%28odds%20ratio%20%5BOR%5D%2C%200.41%3B%2095%25%20confidence%20interval%20%5BCI%5D%2C%200.20-0.82%3B%20P%5Cu200a%3D%5Cu200a0.01%29.%20Moreover%2C%20mortality%20was%20significantly%20reduced%20for%20patients%20taking%2081%5Cu200amg%20of%20ASA%20%281.4%25%29%20compared%20with%20325%5Cu200amg%20%282.9%25%29%20or%20none%20%283.9%25%29.%20Multivariate%20analysis%20demonstrated%20that%2081%5Cu200amg%20of%20ASA%20decreased%20mortality%20risk%20by%2066%25%20%28OR%2C%200.34%3B%2095%25%20CI%2C%200.18-0.66%3B%20P%5Cu200a%26lt%3B%5Cu200a0.01%29%2C%20whereas%20325%5Cu200amg%20of%20ASA%20had%20no%20mortality%20benefit%20%28OR%2C%200.74%3B%2095%25%20CI%2C%200.41-1.35%3B%20P%5Cu200a%3D%5Cu200a0.33%29%20compared%20with%20no%20ASA.%5CnCONCLUSIONS%3A%20Low-dose%20ASA%20use%20within%2024%5Cu200ahours%20of%20CABG%20is%20independently%20associated%20with%20decreased%20early%20postoperative%20mortality.%22%2C%22date%22%3A%22Dec%202015%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FSLA.0000000000000951%22%2C%22ISSN%22%3A%221528-1140%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22BJSZ96GT%22%2C%22394YLKLW%22%2C%22WI5Z8WFT%22%2C%22C8D9UJBP%22%5D%2C%22dateModified%22%3A%222022-01-24T21%3A58%3A55Z%22%7D%7D%2C%7B%22key%22%3A%2262KK2SET%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lasala%20et%20al.%22%2C%22parsedDate%22%3A%222015-06%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLasala%2C%20J.%20D.%2C%20Tolpin%2C%20D.%20A.%2C%20Collard%2C%20C.%20D.%20et%20al.%20%282015%29.%20Real-time%20transesophageal%20echocardiography%20for%20left%20atrial%20appendage%20ligation%20using%20the%20LARIAT%20snare%20device.%20%26lt%3Bi%26gt%3BAnesth%20Analg%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B120%26lt%3B%5C%2Fi%26gt%3B%2C%201204%26%23x2013%3B1207.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1213%5C%2FANE.0000000000000648%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1213%5C%2FANE.0000000000000648%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Real-time%20transesophageal%20echocardiography%20for%20left%20atrial%20appendage%20ligation%20using%20the%20LARIAT%20snare%20device%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Javier%20D.%22%2C%22lastName%22%3A%22Lasala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20A.%22%2C%22lastName%22%3A%22Tolpin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20D.%22%2C%22lastName%22%3A%22Collard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wei%22%2C%22lastName%22%3A%22Pan%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22Jun%202015%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1213%5C%2FANE.0000000000000648%22%2C%22ISSN%22%3A%221526-7598%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22394YLKLW%22%2C%22WI5Z8WFT%22%2C%22C8D9UJBP%22%5D%2C%22dateModified%22%3A%222018-05-14T21%3A52%3A22Z%22%7D%7D%2C%7B%22key%22%3A%2288V7JIXV%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Munoz%20et%20al.%22%2C%22parsedDate%22%3A%222014-04%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMunoz%2C%20E.%2C%20Briggs%2C%20H.%2C%20Tolpin%2C%20D.%20A.%20et%20al.%20%282014%29.%20Low%20serum%20sodium%20level%20during%20cardiopulmonary%20bypass%20predicts%20increased%20risk%20of%20postoperative%20stroke%20after%20coronary%20artery%20bypass%20graft%20surgery.%20%26lt%3Bi%26gt%3BJ%20Thorac%20Cardiovasc%20Surg%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B147%26lt%3B%5C%2Fi%26gt%3B%2C%201351%26%23x2013%3B1355.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jtcvs.2013.09.034%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jtcvs.2013.09.034%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Low%20serum%20sodium%20level%20during%20cardiopulmonary%20bypass%20predicts%20increased%20risk%20of%20postoperative%20stroke%20after%20coronary%20artery%20bypass%20graft%20surgery%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizandro%22%2C%22lastName%22%3A%22Munoz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Holly%22%2C%22lastName%22%3A%22Briggs%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20A.%22%2C%22lastName%22%3A%22Tolpin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vei-Vei%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Terry%22%2C%22lastName%22%3A%22Crane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Macarthur%20A.%22%2C%22lastName%22%3A%22Elayda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20D.%22%2C%22lastName%22%3A%22Collard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wei%22%2C%22lastName%22%3A%22Pan%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVE%3A%20Rapid%20decreases%20in%20serum%20sodium%20levels%20are%20associated%20with%20altered%20mental%20status%2C%20seizures%2C%20and%20coma.%20During%20cardiac%20surgery%2C%20serum%20sodium%20levels%20decrease%20rapidly%20when%20cardiopulmonary%20bypass%20is%20initiated%20because%20cardiopulmonary%20bypass%20causes%20hemodilution.%20However%2C%20whether%20this%20decrease%20influences%20neurologic%20outcome%20after%20cardiac%20surgery%20remains%20unclear.%20We%20investigated%20whether%20the%20average%20serum%20sodium%20level%20during%20cardiopulmonary%20bypass%20is%20independently%20predictive%20of%20postoperative%20stroke%20or%2030-day%20all-cause%20mortality%20in%20patients%20who%20undergo%20primary%20coronary%20artery%20bypass%20grafting.%5CnMETHODS%3A%20In%20a%20single-institution%2C%20retrospective%20cohort%20of%202348%20consecutive%20patients%20who%20underwent%20primary%2C%20isolated%20coronary%20artery%20bypass%20grafting%2C%20sequential%20multivariate%20logistic%20regression%20was%20performed%20to%20determine%20the%20threshold%20below%20which%20the%20average%20serum%20sodium%20level%20during%20cardiopulmonary%20bypass%20independently%20predicts%20postoperative%20stroke%20or%20early%20death.%20To%20further%20test%20the%20validity%20of%20this%20threshold%20and%20to%20control%20for%20selection%20bias%2C%20stepwise%20multivariate%20logistic%20regression%20was%20also%20performed%20on%20propensity%20score-matched%20patients%20%28n%5Cu00a0%3D%5Cu00a0924%29.%5CnRESULTS%3A%20An%20average%20serum%20sodium%20level%20less%20than%20130%20mEq%5C%2FL%20during%20cardiopulmonary%20bypass%20was%20independently%20predictive%20of%20stroke%2C%20both%20in%20the%20entire%20study%20cohort%20%281.44%25%20vs%202.92%25%3B%20odds%20ratio%2C%202.09%3B%2095%25%20confidence%20interval%2C%201.1-4.1%3B%20P%5Cu00a0%3D%5Cu00a0.03%29%20and%20in%20the%20propensity-matched%20patients%20%280.9%25%20vs%203.0%25%3B%20odds%20ratio%2C%204.1%3B%2095%25%20confidence%20interval%2C%201.3-13.0%3B%20P%5Cu00a0%3D%5Cu00a0.02%29.%20The%20average%20serum%20sodium%20level%20during%20cardiopulmonary%20bypass%20was%20not%20independently%20associated%20with%20early%20death%2C%20regardless%20of%20what%20threshold%20value%20was%20used.%5CnCONCLUSIONS%3A%20An%20average%20serum%20sodium%20level%20of%20less%20than%20130%20mEq%5C%2FL%20during%20cardiopulmonary%20bypass%20is%20independently%20associated%20with%20an%20increased%20risk%20of%20postoperative%20stroke%20in%20patients%20who%20undergo%20primary%20coronary%20artery%20bypass%20grafting.%22%2C%22date%22%3A%22Apr%202014%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jtcvs.2013.09.034%22%2C%22ISSN%22%3A%221097-685X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22394YLKLW%22%2C%22WI5Z8WFT%22%2C%22YYWWBJHS%22%5D%2C%22dateModified%22%3A%222018-05-02T20%3A48%3A19Z%22%7D%7D%5D%7D
Morkos, M., DeLeon, A., Koeckert, M. et al. (2023). The use of unilateral erector spinae plane block in minimally invasive cardiac surgery. J Cardiothorac Vasc Anesth 37, 432–436. https://doi.org/10.1053/j.jvca.2022.11.039.
Shi, J., Zhou, C., Pan, W. et al. (2022). Effect of high- vs low-dose tranexamic acid infusion on need for red blood cell transfusion and adverse events in patients undergoing cardiac surgery: The OPTIMAL randomized clinical trial. JAMA 328, 336–347. https://doi.org/10.1001/jama.2022.10725.
Qiu, J., Luo, X., Wu, J. et al. (2021). A new aortic arch dissection classification: the Fuwai classification. Front Cardiovasc Med 8, 710281. https://doi.org/10.3389/fcvm.2021.710281.
Schutz, A., Zhang, Q., Bertapelle, K. et al. (2020). Del Nido cardioplegia in coronary surgery: a propensity-matched analysis. Interact Cardiovasc Thorac Surg 30, 699–705. https://doi.org/10.1093/icvts/ivaa010.
Shi, J., Zhou, C., Liu, S. et al. (2020). Outcome impact of different tranexamic acid regimens in cardiac surgery with cardiopulmonary bypass (OPTIMAL): Rationale, design, and study protocol of a multicenter randomized controlled trial. Am Heart J 222, 147–156. https://doi.org/10.1016/j.ahj.2019.09.010.
Curtis, M., Deng, Y., Lee, V.-V. et al. (2017). Effect of dose and timing of preoperative statins on mortality after coronary artery bypass surgery. Ann Thorac Surg 104, 782–789. https://doi.org/10.1016/j.athoracsur.2016.12.043.
Wei, P., Cao, Y., Zhang, Y. et al. (2016). On robust association testing for quantitative traits and rare variants. G3 (Bethesda) 6, 3941–3950. https://doi.org/10.1534/g3.116.035485.
Deng, Y., Pisklak, P. V., Lee, V.-V. et al. (2015). Association between preoperative aspirin-dosing strategy and mortality after coronary artery bypass graft surgery. Ann Surg 262, 1150–1156. https://doi.org/10.1097/SLA.0000000000000951.
Lasala, J. D., Tolpin, D. A., Collard, C. D. et al. (2015). Real-time transesophageal echocardiography for left atrial appendage ligation using the LARIAT snare device. Anesth Analg 120, 1204–1207. https://doi.org/10.1213/ANE.0000000000000648.
Munoz, E., Briggs, H., Tolpin, D. A. et al. (2014). Low serum sodium level during cardiopulmonary bypass predicts increased risk of postoperative stroke after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg 147, 1351–1355. https://doi.org/10.1016/j.jtcvs.2013.09.034.